Sfoglia per AUTORE
PIROSA MC
Collezione ASL Biella

  

Items : 3

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Zucca E; Pisani F; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Vitolo U; Zanni M; Ghiggi C; Celli M; Annibali O; Liberati AM; Cabras MG; Orsucci L; Bruna R; Gaidano G; Balzarotti M; Merli F; Tucci A; Vanazzi A; Sassone M; Ferreri AJM; Botto B; Stathis A; Chiappella A; Tani M; Conconi A; et alii...

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. in Haematologica / Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino

Thieblemont C; Zucca E; Luminari S; Bertoni F; Rossi D; Cavalli F; Pietrantuono G; Re F; Spina M; Landi F; Houot R; Merli M; Liberati AM; Haioun C; Cartron G; Devizzi L; Occhini U; Casasnovas RO; Califano C; Celli M; Pulsoni A; Angrilli F; Conconi A; Tessoulin B; Tilly H; Zanni M; Cabras MG; Capochiani E; Morschhauser F; et alii...

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome. in British journal of haematology / Br J Haematol. 2019 Nov;187(4):478-487. doi: 10.1111/bjh.16106. Epub 2019 Aug 5.

2019
ASL Biella
AOU Novara

Zucca E; Gaidano G; Stathis A; Rossi D; Moccia AA; Moia R; Pirosa MC; Nassi L; Winkler J; Cascione L; Margiotta Casaluci G; Conconi A; Vannata B;